This association may be related to pathophysiological alterations in chronic kidney disease, such as secondary hyperparathyroidism, altered metabolism of the active form of vitamin D, phosphorus retention, chronic metabolic acidosis, increased levels of sclerostin and FGF23. Here, FGF23 is linked to secondary hyperparathyroidism.